The institutional landscape for Acrivon Therapeutics, Inc. (NASDAQ:ACRV) includes 47 filers as of the latest reporting cycle ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 8,340,508 | 0 | 0.00% | $20,100,624.00 |
| Sands Capital Alternatives, LLC | 31 Dec, 2025 | 2,122,605 | 0 | 0.00% | $5,115,478.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 1,641,884 | 100,558 | 6.52% | $3,956,941.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 888,130 | 0 | 0.00% | $2,140,393.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 698,857 | 72,709 | 11.61% | $1,684,246.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 634,169 | 10,769 | 1.73% | $1,528,347.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 585,069 | 265,864 | 83.29% | $1,410,016.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 581,208 | 489,204 | 531.72% | $1,400.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 496,081 | 346,366 | 231.35% | $1,195,556.00 |
| ACORN CAPITAL ADVISORS, LLC | 31 Dec, 2025 | 405,237 | 0 | 0.00% | $976,622.00 |
| UBS Group AG | 31 Dec, 2025 | 348,541 | -334,677 | -48.99% | $839,984.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 342,071 | 52,823 | 18.26% | $824,391.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 333,773 | 197,273 | 144.52% | $804,393.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 205,124 | -125,833 | -38.02% | $494,349.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 198,223 | 6,190 | 3.22% | $477,891.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 121,524 | -63,710 | -34.39% | $292,873.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 119,422 | 99,680 | 504.91% | $287,807.00 |
| STATE STREET CORP | 31 Dec, 2025 | 67,145 | 0 | 0.00% | $161,819.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 63,718 | 21,552 | 51.11% | $153,561.00 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 48,015 | 48,015 | 0.00% | $115,716.00 |